Circulating estradiol and mortality in men with systolic chronic heart failure

JAMA

Volumn 301, Issue 18, 2009, Pages 1892-1901

  Jankowska, Ewa A ^a,b,c   Rozentryt, Piotr ^d   Ponikowska, Beata ^c   Hartmann, Oliver ^e   Kustrzycka Kratochwil, Dorota ^a   Reczuch, Krzysztof ^a,c   Nowak, Jolanta ^d   Borodulin Nadzieja, Ludmila ^c   Polonski, Lech ^d   Banasiak, Waldemar ^a   Poole Wilson, Philip A ^g   Anker, Stefan D ^e,f   Ponikowski, Piotr ^a,c  

^a MILITARY HOSPITAL   (Poland)

^b INSTITUTE OF ANTHROPOLOGY   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f IRCCS SAN RAFFAELE PISANA   (Italy)

^g ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANDROGEN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; LOOP DIURETIC AGENT; PRASTERONE SULFATE; SODIUM; SPIRONOLACTONE; TESTOSTERONE; THIAZIDE DIURETIC AGENT;

ADIPOSE TISSUE; ADULT; AGE DISTRIBUTION; ANDROGEN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ESTRADIOL BLOOD LEVEL; FOLLOW UP; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE METABOLISM; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POLAND; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; SYSTOLIC HEART FAILURE; TERTIARY HEALTH CARE; TESTOSTERONE BLOOD LEVEL; AGED; BLOOD; CHRONIC DISEASE; HEART STROKE VOLUME; MIDDLE AGED;

AGED; CHRONIC DISEASE; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TESTOSTERONE;

EID: 65549146657     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.639     Document Type: Article

References (43)

1. Grumbach MM, Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab. 1999;84(12):4677- 4694.
2. Jones ME, Boon WC, Proietto J, Simpson ER. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab. 2006;17(2):55-64. (Pubitemid 43306728)
3. Rochira V, Balestrieri A, Madeo B, Spaggiari A, Carani C. Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men. Mol Cell Endocrinol. 2002;193(1-2):19-28.
4. Kim JK, Levin ER. Estrogen signaling in the cardiovascular system. Nucl Recept Signal. 2006;4:e013.
5. Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res. 2002;53(3):709-719. (Pubitemid 34175263)
6. Sudhir K, Komesaroff PA. Clinical review 110: cardiovascular actions of estrogens in men. J Clin Endocrinol Metab. 1999;84(10):3411-3415. (Pubitemid 30645184)
7. Xin HB, Senbonmatsu T, Cheng DS, et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature. 2002;416(6878):334-338. (Pubitemid 34260249)
8. Li J, Wu M, Que L, et al. 17Beta-estradiol attenuates cardiac dysfunction and decreases NF-kappaB binding activity in mechanically stretched rat hearts. Steroids. 2008;73(7):720-726.
9. Satoh M, Matter CM, Ogita H, et al. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation. 2007;115(25):3197-3204. (Pubitemid 47012234)
10. Lee TM, Lin MS, Chou TF, Tsai CH, Chang NC. Adjunctive 17beta-estradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein. Cardiovasc Res. 2004;63(1):109-117. (Pubitemid 38759815)
11. Kadokami T, McTiernan CF, Higuichi Y, Frye CS, Kubota T, Feldman AM. 17Beta-estradiol improves survival in male mice with cardiomyopathy induced by cardiac-specific tumor necrosis factor-alpha overexpression. J Interferon Cytokine Res. 2005;25(5):254-260. (Pubitemid 40664422)
12. Arnlöv J, Pencina MJ, Amin S, et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med. 2006;145(3):176-184. (Pubitemid 46780562)
13. Abbott RD, Launer LJ, Rodriguez BL, et al. Serum estradiol and risk of stroke in elderly men. Neurology. 2007;68(8):563-568. (Pubitemid 46303602)
14. Angstwurm MW, Gaertner R, Schopohl J. Outcome in elderly patients with severe infection is influenced by sex hormones but not gender. Crit Care Med. 2005;33(12):2786-2793. (Pubitemid 41816413)
15. Mahmoodzadeh S, Eder S, Nordmeyer J, et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. FASEB J. 2006;20(7):926-934.
16. Jankowska EA, Biel B, Majda J, et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation. 2006;114(17):1829-1837. (Pubitemid 44673358)
17. Anker SD, Clark AL, Kemp M, et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol. 1997;30(4):997-1001. (Pubitemid 27435893)
18. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96(2):526-534. (Pubitemid 27329429)
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461-470.
20. Harrell FE. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
21. Muller M, van der Schouw YT, Thijssen JH, Grobbee DE. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab. 2003;88(11):5076-5086. (Pubitemid 37452697)
22. Murata Y, Robertson KM, Jones ME, Simpson ER. Effect of estrogen deficiency in the male: the ArKO mouse model. Mol Cell Endocrinol. 2002;193(1-2):7-12.
23. Maffei L, Murata Y, Rochira V, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab. 2004;89(1):61-70. (Pubitemid 38183860)
24. Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1997;18(2):259-269. (Pubitemid 27107588)
25. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349(9058):1050-1053. (Pubitemid 27158249)
26. Friedman HS, Cirillo N, Schiano F, et al. Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances. Alcohol Clin Exp Res. 1995;19(1):123-129.
27. Yu AM, Fukamachi K, Krausz KW, Cheung C, Gonzalez FJ. Potential role for human cytochrome P450 3A4 in estradiol homeostasis. Endocrinology. 2005;146(7):2911-2919. (Pubitemid 41002798)
28. Song WC, Qian Y, Li AP. Estrogen sulfotransferase expression in the human liver: marked interindividual variation and lack of gender specificity. J Pharmacol Exp Ther. 1998;284(3):1197-1202. (Pubitemid 28130851)
29. Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, Vary CP. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab. 2006;291(3):E631-E638. (Pubitemid 44352271)
30. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men: a prospective population-based study. Circulation. 1988;78(3):539-545. (Pubitemid 18211274)
31. Kunnas TA, Laippala P, Penttilä A, Lehtimäki T, Karhunen PJ. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ. 2000;321(7256):273-274. (Pubitemid 30487465)
32. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, et al. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation. 2007;115(7):861-871. (Pubitemid 46294727)
33. Shearman AM, Cupples LA, Demissie S, et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA. 2003;290(17):2263-2270. (Pubitemid 37430558)
34. Shearman AM, Cooper JA, Kotwinski PJ, et al. Estrogen receptor alpha gene variation and the risk of stroke. Stroke. 2005;36(10):2281-2282. (Pubitemid 41429261)
35. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol. 2003;284(5):H1560-H1569. (Pubitemid 36460767)
36. Zhou L, Shao Y, Huang Y, Yao T, Lu LM. 17beta-estradiol inhibits angiotensin II-induced collagen synthesis of cultured rat cardiac fibroblasts via modulating angiotensin II receptors. Eur J Pharmacol. 2007;567(3):186-192. (Pubitemid 46976891)
37. Förster C, Kietz S, Hultenby K, Warner M, Gustafsson JA. Characterization of the ERbeta-/-mouse heart. Proc Natl Acad Sci U S A. 2004;101(39):14234-14239.
38. Nakamura S, Yoshimura M, Nakayama M, et al. Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart. Circulation. 2004;110(13):1787-1793. (Pubitemid 39299221)
39. Iwakura A, Shastry S, Luedemann C, et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation. 2006;113(12):1605-1614. (Pubitemid 43739420)
40. Hamada H, Kim MK, Iwakura A, et al. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 2006;114(21):2261-2270.
41. Adamopoulos S, Leftheriotis D, Sbarouni E, Karavolias G, Kremastinos DT. Acute haemodynamic effects of oestrogen administration in male patients with chronic heart failure. Eur J Heart Fail. 2002;4(6):719-726. (Pubitemid 35403080)
42. Komesaroff PA, Fullerton M, Esler MD, Dart A, Jennings G, Sudhir K. Low-dose estrogen supplementation improves vascular function in hypogonadal men. Hypertension. 2001;38(5):1011-1016. (Pubitemid 34252798)
43. Yoshioka J, Hasegawa S, Node K, et al. Oestrogen increases myocardial blood flow in men: assessment by 13N-ammonia positron emission tomography. Nucl Med Commun. 2004;25(6):557-562. (Pubitemid 38703878)